MediWound (MDWD)
(Real Time Quote from BATS)
$17.80 USD
+0.19 (1.08%)
Updated Sep 13, 2024 10:28 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for MediWound Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 19 | 27 | 24 | 22 | 32 |
Cost Of Goods | 15 | 13 | 15 | 14 | 12 |
Gross Profit | 4 | 13 | 9 | 8 | 20 |
Selling & Adminstrative & Depr. & Amort Expenses | 19 | 22 | 20 | 16 | 15 |
Income After Depreciation & Amortization | -15 | -8 | -11 | -9 | 4 |
Non-Operating Income | 11 | 0 | 0 | 1 | 1 |
Interest Expense | 2 | 12 | 2 | 1 | 3 |
Pretax Income | -7 | -20 | -14 | -9 | 2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | -20 | -14 | -9 | 2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 3 |
Net Income (GAAP) | -7 | -20 | -14 | -9 | 5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -7 | -10 | -8 | 6 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -15 | -8 | -11 | -9 | 4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.01 | 4.99 | 3.89 | 3.89 | 3.88 |
Diluted EPS Before Non-Recurring Items | -0.75 | -3.93 | -3.50 | -2.38 | 0.56 |
Diluted Net EPS (GAAP) | -0.75 | -3.93 | -3.50 | -2.38 | 1.26 |
Fiscal Year end for MediWound Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 5.06 | 4.96 | 5.34 | 4.78 | 4.77 |
Cost Of Goods | 4.62 | 4.36 | 4.62 | 3.88 | 3.64 |
Gross Profit | 0.45 | 0.61 | 0.72 | 0.90 | 1.14 |
SG&A, R&D, and Dept/Amort Expenses | 4.93 | 4.34 | 4.62 | 3.92 | 5.14 |
Income After SG&A, R&D, and Dept/Amort Expenses | -4.48 | -3.73 | -3.90 | -3.02 | -4.00 |
Non-Operating Income | 0.58 | 0.00 | 3.27 | 0.88 | 5.83 |
Interest Expense | 2.41 | 5.97 | 1.00 | 0.00 | 0.89 |
Pretax Income | -6.31 | -9.71 | -1.62 | -2.15 | 0.93 |
Income Taxes | 0.00 | 0.02 | 0.13 | 0.05 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.31 | -9.73 | -1.74 | -2.20 | 0.92 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.31 | -9.73 | -1.74 | -2.20 | 0.92 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 9.28 | 9.23 | 9.22 | 9.22 | 9.21 |
Diluted EPS Before Non-Recurring Items | -0.68 | -0.39 | -0.19 | -0.24 | 0.10 |
Diluted Net EPS (GAAP) | -0.68 | -1.05 | -0.17 | -0.24 | 0.10 |